Economic TimesLean R·
Zydus Lifesciences shares drop 3% after Q1 earnings. Here's why Nuvama upgraded rating, hiked target
Shares of Zydus Lifesciences fell over 2% to Rs 1,151 on the BSE in Wednesday's early trade after the company reported a 36% year-on-year decline in consolidated net profit to Rs 939.8 crore for the first quarter of FY27, compared with Rs 1,467 crore in the year-ago quarter.Zydus Lifesciences had announced its results on Tuesday, following which the stock rallied over 6% to close at Rs 1,191 apiece. While net profit contracted, revenue from operations increased nearly 22% YoY to Rs 8,017 crore …
Read at Economic Times →
